speb/financial-data huggingface dataset:
ADN.TO balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 8576000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5532000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5532000.00
ADN.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 17566031.00
ADN.TO income_statement (annual, 2024-12-31) — Basic EPS: 1.24
ADN.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1831000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 14619000.00
ADN.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -10499000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 156267000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Capital Stock: 156267000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 15250000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 15250000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 15250000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 15250000.00
ADN.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -11488000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -2588000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 15250000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Cash Financial: 15250000.00
ADN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -11488000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -2588000.00
ADN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -9139000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 800000.00
ADN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 34046000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2419000.00
ADN.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -501000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Change In Inventory: -67000.00
ADN.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 463000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 180000.00
ADN.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1552000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -1747000.00
ADN.TO cash_flow (annual, 2024-12-31) — Change In Receivables: 725000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Change In Receivables: 1918000.00
ADN.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 2239000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 284000.00
ADN.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 725000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 1918000.00
ADN.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 13419000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Changes In Cash: 631000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Common Stock: 156267000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Common Stock: 156267000.00
ADN.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -11488000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -2588000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 339029000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 339029000.00
ADN.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 77920000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 14507000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Current Assets: 25920000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Current Assets: 25920000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Current Debt: 46045000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Current Debt: 46045000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 46045000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 46045000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 62322000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 62322000.00
ADN.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 9250000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 2165000.00
ADN.TO cash_flow (annual, 2024-12-31) — Deferred Tax: 9250000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Deferred Tax: 2165000.00
ADN.TO cash_flow (annual, 2024-12-31) — Depreciation: 517000.00
ADN.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 517000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 148000.00
ADN.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 517000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 148000.00
ADN.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 517000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 148000.00
ADN.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 517000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 148000.00
ADN.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 17566031.00
ADN.TO income_statement (annual, 2024-12-31) — Diluted EPS: 1.24
ADN.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 5585000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 5126000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 5126000.00
ADN.TO income_statement (annual, 2024-12-31) — EBIT: 34109000.00
ADN.TO income_statement (quarterly, 2024-12-31) — EBIT: 8471000.00
ADN.TO income_statement (annual, 2024-12-31) — EBITDA: 34626000.00
ADN.TO income_statement (quarterly, 2024-12-31) — EBITDA: 8619000.00
ADN.TO cash_flow (annual, 2024-12-31) — End Cash Position: 15250000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — End Cash Position: 15250000.00
ADN.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -11488000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -2588000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Fixed Assets Revaluation Reserve: 38666000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Fixed Assets Revaluation Reserve: 38666000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: 30993000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: 30993000.00
ADN.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 23547000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 2419000.00
ADN.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -9911000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -4920000.00
ADN.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -539000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: -336000.00
ADN.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 539000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 336000.00
ADN.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 9911000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 4920000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 69659000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 69659000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 6140000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 6140000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 109599000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 109599000.00
ADN.TO income_statement (annual, 2024-12-31) — Gross Profit: 38265000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Gross Profit: 5719000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 229000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 229000.00
ADN.TO income_statement (annual, 2024-12-31) — Interest Expense: 3121000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Interest Expense: 721000.00
ADN.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3121000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 721000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Inventory: 2094000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Inventory: 2094000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 453970000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Invested Capital: 453970000.00
ADN.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -9139000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 800000.00
ADN.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 10298000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
ADN.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 105243000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 105243000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 68896000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 68896000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 68896000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 68896000.00
ADN.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
ADN.TO balance_sheet (annual, 2024-12-31) — Net Debt: 99691000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Net Debt: 99691000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Income: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Income: 5585000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 5585000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 5585000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 5585000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 5585000.00
ADN.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 21738000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 5585000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 21738000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 5585000.00
ADN.TO income_statement (annual, 2024-12-31) — Net Interest Income: -3121000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Interest Income: -721000.00
ADN.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ADN.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -3121000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -721000.00
ADN.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -10499000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -560000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Net PPE: 104067000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Net PPE: 104067000.00
ADN.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -9139000.00
ADN.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
ADN.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 332889000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 332889000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 137770000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 137770000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 137770000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 137770000.00
ADN.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 24176000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 3363000.00
ADN.TO income_statement (annual, 2024-12-31) — Normalized Income: 14407352.65
ADN.TO income_statement (quarterly, 2024-12-31) — Normalized Income: 1797289.03
ADN.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 34046000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 2419000.00
ADN.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -10450000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -5256000.00
ADN.TO income_statement (annual, 2024-12-31) — Operating Income: 23659000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Operating Income: 3215000.00
ADN.TO income_statement (annual, 2024-12-31) — Operating Revenue: 116185000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Operating Revenue: 20226000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 17675687.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 17675687.00
ADN.TO income_statement (annual, 2024-12-31) — Other Income Expense: 10450000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Other Income Expense: 5256000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Other Inventories: 2094000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Other Inventories: 2094000.00
ADN.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 14178000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 0.00
ADN.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 471890000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 471890000.00
ADN.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 1569000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 138000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Other Properties: 4356000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 4356000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Payables: 16277000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Payables: 16277000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 16277000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 16277000.00
ADN.TO income_statement (annual, 2024-12-31) — Pretax Income: 30988000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Pretax Income: 7750000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -10499000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
ADN.TO balance_sheet (annual, 2024-12-31) — Receivables: 8576000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Receivables: 8576000.00
ADN.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 77920000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 14507000.00
ADN.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 517000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 148000.00
ADN.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -10298000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
ADN.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 113103000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 113103000.00
ADN.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 1360000.00
ADN.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 13037000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Selling General And Administration: 2218000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Share Issued: 17675687.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Share Issued: 17675687.00
ADN.TO cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 10298000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -10298000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
ADN.TO income_statement (annual, 2024-12-31) — Special Income Charges: 539000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 336000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 339029000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 339029000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 332889000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 332889000.00
ADN.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 3119352.65
ADN.TO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 1468289.03
ADN.TO income_statement (annual, 2024-12-31) — Tax Provision: 9250000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Tax Provision: 2165000.00
ADN.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.30
ADN.TO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.28
ADN.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 0.00
ADN.TO cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -3426000.00
ADN.TO cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -507000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Assets: 608017000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Assets: 608017000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 407925000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 407925000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Debt: 114941000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Debt: 114941000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 339029000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 339029000.00
ADN.TO income_statement (annual, 2024-12-31) — Total Expenses: 92526000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Total Expenses: 17011000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 268988000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 268988000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 582097000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 582097000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 206666000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 206666000.00
ADN.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 23659000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 3215000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 229000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 229000.00
ADN.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 10450000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 5256000.00
ADN.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 10450000.00
ADN.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 5256000.00
ADN.TO balance_sheet (annual, 2024-12-31) — Working Capital: -36402000.00
ADN.TO balance_sheet (quarterly, 2024-12-31) — Working Capital: -36402000.00
ADN.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 3052000.00
ADN.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 24834000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8598000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7529000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5843000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 17423810.00
ADN.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.21
ADN.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 15250000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 158791000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4629000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4629000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2590000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -455000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8818000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1348000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1101000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -123000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2681000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1047000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2858000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1047000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -10621000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 158791000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2590000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 339709000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 17361000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 16868000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 715000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 715000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 14482000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 1522000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 1522000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 236000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 236000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 17423810.00
ADN.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.21
ADN.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 3659000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 5169000.00
ADN.TO income_statement (quarterly, 2025-03-31) — EBIT: 5997000.00
ADN.TO income_statement (quarterly, 2025-03-31) — EBITDA: 6233000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 4629000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -455000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 38666000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 30659000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1348000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -22000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 22000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1554000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 69325000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 6369000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 118319000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 7473000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 0.00
ADN.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 816000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 816000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 3195000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 455758000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8818000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 2189000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 104964000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 115334000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 115334000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 2189000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -54000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -6510000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 111420000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Income: 3659000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 3659000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3659000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3659000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3659000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 3659000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3659000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -816000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 2135000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 2135000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -816000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -2308000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 112476000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 333340000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 138455000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 138455000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4657000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 2545974.72
ADN.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1348000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -22000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Operating Income: 4421000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 24834000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 17822449.00
ADN.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 1576000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Other Inventories: 3195000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1554000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 472267000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 242000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 13355000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Payables: 13767000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 13767000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 5181000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -6510000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 9044000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 17361000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 236000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -54000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 111593000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2810000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 17822449.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
ADN.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: 22000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 339709000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 333340000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 462974.72
ADN.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 1522000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
ADN.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 1515000.00
ADN.TO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -2331000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 607980000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 455043000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 116049000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 339709000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 20413000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 268271000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 591112000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 253789000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 4421000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
ADN.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1576000.00
ADN.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1576000.00
ADN.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 2386000.00
ADN.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 3994000.00
ADN.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 17129000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8736000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 8330000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -6169000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 17947895.00
ADN.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.15
ADN.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4629000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -258000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 161405000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2645000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2645000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2591000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2757000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -95000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 868000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1974000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1333000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 494000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -801000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 334000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -801000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1984000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 161405000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2591000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 336768000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11437000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 14111000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 715000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 715000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 14664000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 906000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 906000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 581000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 581000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 17947895.00
ADN.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.15
ADN.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2667000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 5213000.00
ADN.TO income_statement (quarterly, 2025-06-30) — EBIT: 4642000.00
ADN.TO income_statement (quarterly, 2025-06-30) — EBITDA: 5223000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 2645000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2757000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Fixed Assets Revaluation Reserve: 38666000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 27650000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 610000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2808000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -136000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 136000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2808000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 66316000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 6320000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 115874000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 5692000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
ADN.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 1069000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1069000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 1221000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 447499000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -95000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 102638000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 110016000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 110016000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -166000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 108086000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Income: 2667000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2667000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2667000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2667000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2667000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2667000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2667000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -1069000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -166000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -166000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1069000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 109705000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -95000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 0.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 330448000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 137158000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 137158000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2279000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 469505.46
ADN.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 868000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2944000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Operating Income: 1698000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 17129000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 17976713.00
ADN.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 2944000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Other Inventories: 1221000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 468470000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 424000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 13236000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Payables: 13949000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13949000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 3573000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -258000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 10245000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11437000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 581000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -166000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 109047000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 163000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3570000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 17976713.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
ADN.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 136000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 336768000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 330448000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 746505.46
ADN.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 906000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
ADN.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1915000.00
ADN.TO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -676000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 598606000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 446784000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 110731000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 336768000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 15431000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 261838000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 584495000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 247174000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1698000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
ADN.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 2944000.00
ADN.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 2944000.00
ADN.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -553000.00
ADN.TO income_statement (annual, 2025-12-31) — +Operating Expense: 13209000.00
ADN.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 2731000.00
ADN.TO income_statement (annual, 2025-12-31) — +Total Revenue: 86956000.00
ADN.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 21976000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 12212000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 12212000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 9154000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 9154000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7012000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7012000.00
ADN.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 18157708.00
ADN.TO income_statement (annual, 2025-12-31) — Basic EPS: 2.70
ADN.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 15250000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2426000.00
ADN.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -3205000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 166693000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 166693000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4808000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4808000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4808000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4808000.00
ADN.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -10363000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2590000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 4808000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 4808000.00
ADN.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8744000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2762000.00
ADN.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8521000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 522000.00
ADN.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 6823000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4622000.00
ADN.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -938000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -887000.00
ADN.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1103000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 45000.00
ADN.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1289000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2973000.00
ADN.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -578000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1056000.00
ADN.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1330000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1075000.00
ADN.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -578000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1056000.00
ADN.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -10442000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2382000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Common Stock: 166693000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 166693000.00
ADN.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -10363000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2590000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 359744000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 359744000.00
ADN.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 60431000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 15004000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Current Assets: 16994000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 16994000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Current Debt: 698000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 698000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 698000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 698000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 19566000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 19566000.00
ADN.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 18560000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 15960000.00
ADN.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 18560000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 15960000.00
ADN.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1882000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 513000.00
ADN.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1882000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 513000.00
ADN.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 18157708.00
ADN.TO income_statement (annual, 2025-12-31) — Diluted EPS: 2.70
ADN.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 48973000.00